U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
157351157351A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal CancerActive, not recruitingHas ResultsColorectal|CancerDrug: Vandetanib|Drug: FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acidhttps://ClinicalTrials.gov/show/NCT00500292
157352157352Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis TrialRecruitingNo Results AvailableAngioplasty, Transluminal, Percutaneous Coronary|Coronary RestenosisDrug: Celecoxibhttps://ClinicalTrials.gov/show/NCT00500279
157353157353Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly SubjectsCompletedHas ResultsPneumococcal InfectionsBiological: 13-valent Pneumococcal Conjugate Vaccine (13vPnC)https://ClinicalTrials.gov/show/NCT00500266
157354157354Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With AsthmaRecruitingNo Results AvailableAsthmaDevice: exhaled nitric oxide measurement|Procedure: bronchial hyperresponsiveness with methacholine (PC20M)|Procedure: symptom score diary (according to 2007 GINA guidelines)https://ClinicalTrials.gov/show/NCT00500253
157355157355Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)TerminatedHas ResultsLeukemia|LymphomaDrug: Insulin Glargine|Drug: Insulin Asparthttps://ClinicalTrials.gov/show/NCT00500240
157356157356Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following SurgeryCompletedNo Results AvailableAcromegalyhttps://ClinicalTrials.gov/show/NCT00500227
157357157357Ilioinguinal Nerve Excision in Open Mesh Repair of Inguinal Hernia,a Randomized Clinical TrialCompletedNo Results AvailablePostoperative Pain|Postoperative HyposthesiaProcedure: elective ilioinguinal nerve excisionhttps://ClinicalTrials.gov/show/NCT00500214
157358157358A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.CompletedNo Results AvailableSchizophreniaDrug: SB- 773812https://ClinicalTrials.gov/show/NCT00500201
157359157359Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GISTCompletedNo Results AvailableGastrointestinal Stromal TumorsDrug: Imatinib Mesylate (Gleevec)https://ClinicalTrials.gov/show/NCT00500188
157360157360Novel Home Care Device for High-Risk Diabetic PatientsRecruitingNo Results AvailableDiabetes|Neuropathic Limb|Elevated Temperature|Shear Pressure|Increased TemperaturesDevice: TempTouchRM|Device: Offloadinghttps://ClinicalTrials.gov/show/NCT00500175
157361157361Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of MelasmaCompletedNo Results AvailableMelasmaBehavioral: Tri-Luma Maintenance regimenhttps://ClinicalTrials.gov/show/NCT00500162
157362157362A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedHas ResultsADHDDrug: Vyvanse (lisdexamfetamine dimesylate)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00500149
157363157363The Psychosocial Effect of Thoughts of Personal Mortality on Cardiac Risk Assessment by Medical StudentsCompletedNo Results AvailablePrejudice|BiasProcedure: mortality saliencehttps://ClinicalTrials.gov/show/NCT00500136
157364157364Alpha-1 Coded Testing(ACT) StudyRecruitingNo Results AvailableAlpha-1 Antitrypsin DeficiencyProcedure: Alpha-1 Antitrypsin Genotypehttps://ClinicalTrials.gov/show/NCT00500123
157365157365Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate CancerCompletedHas ResultsProstate CancerDrug: Docetaxel|Drug: Imatinib Mesylate|Drug: Leuprolide|Drug: Goserelin Acetatehttps://ClinicalTrials.gov/show/NCT00500110
157366157366Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited TrainingCompletedNo Results AvailableDiabetic RetinopathyDevice: Digital retina image|Device: direct ophthalmoscopy|Procedure: comprehensive eye examhttps://ClinicalTrials.gov/show/NCT00500097
157367157367Phase III ALTU-135 CP Safety TrialTerminatedNo Results AvailableExocrine Pancreatic InsufficiencyDrug: Liprotamasehttps://ClinicalTrials.gov/show/NCT00500084
157368157368Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHDCompletedHas ResultsAttention Deficit Hyperactivity DisorderDrug: Vyvanse (lisdexamfetamine dimesylate)https://ClinicalTrials.gov/show/NCT00500071
157369157369A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18CompletedNo Results AvailableB Cell Non-Hodgkin's Lymphoma|Lymphoma, Non-HodgkinDrug: interleukin-18, Rituxan, Rituximabhttps://ClinicalTrials.gov/show/NCT00500058
157370157370Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein OcclusionsActive, not recruitingNo Results AvailableCentral Retinal Vein Occlusion|Branch Retinal Vein OcclusionDrug: nicotinic acidhttps://ClinicalTrials.gov/show/NCT00500045
157371157371Blood Collection for Use in Serological Assay Development From Healthy Adult VolunteersCompletedNo Results AvailableHealthyProcedure: blood drawhttps://ClinicalTrials.gov/show/NCT00500032
157372157372Uterine Flora During Elective and Urgent Cesarean SectionsCompletedNo Results AvailableEndometritishttps://ClinicalTrials.gov/show/NCT00500019
157373157373A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)TerminatedNo Results AvailableChronic Myelogenous Leukemia|Leukemia, Lymphoblastic, Acute, Philadelphia-PositiveDrug: MK0457|Drug: dasatinibhttps://ClinicalTrials.gov/show/NCT00500006
157374157374Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With AcromegalyCompletedNo Results AvailableAcromegalyDrug: lanreotide (Autogel formulation), duration of treatment 46-48 weekshttps://ClinicalTrials.gov/show/NCT00499993
157375157375Near Infrared/ Ultrasound Dual Modal Imaging for Breast Cancer DiagnosisCompletedNo Results AvailableBreast Neoplasmshttps://ClinicalTrials.gov/show/NCT00499980
157376157376Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital WartsCompletedNo Results AvailableGenital WartsDrug: GS-9191 ointment|Drug: GS-9191|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00499967
157377157377Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 DiabeticsCompletedNo Results AvailableType 1 DiabetesProcedure: Microdialysis|Device: Guardian RT|Device: Glucoday Shttps://ClinicalTrials.gov/show/NCT00499954
157378157378Alpha-1 Foundation Research RegistryRecruitingNo Results AvailableAlpha 1-Antitrypsin Deficiencyhttps://ClinicalTrials.gov/show/NCT00499941
157379157379A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal WomenCompletedNo Results AvailableOsteoporosisDrug: SB-751689https://ClinicalTrials.gov/show/NCT00499928
157380157380NICU Asthma Education and Secondhand Smoke Reduction StudyActive, not recruitingNo Results AvailableRespiratory IllnessBehavioral: Secondhand Smoke Reduction, Smoking Cessation|Behavioral: Asthma Education with Secondhand Smoke Reductionhttps://ClinicalTrials.gov/show/NCT00499915

* Görseller ve İçerik tekif hakkına sahip olabilir